GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Price-to-Owner-Earnings

Arctic Bioscience AS (OSL:ABS) Price-to-Owner-Earnings : (As of May. 21, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Price-to-Owner-Earnings?

As of today (2025-05-21), Arctic Bioscience AS's share price is kr3.50. Arctic Bioscience AS does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Arctic Bioscience AS's Price-to-Owner-Earnings or its related term are showing as below:


OSL:ABS's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 29.47
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-21), Arctic Bioscience AS's share price is kr3.50. Arctic Bioscience AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-1.89. Therefore, Arctic Bioscience AS's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-21), Arctic Bioscience AS's share price is kr3.50. Arctic Bioscience AS's EPS without NRI for the trailing twelve months (TTM) ended in was kr-1.89. Therefore, Arctic Bioscience AS's PE Ratio without NRI for today is At Loss.


Arctic Bioscience AS Price-to-Owner-Earnings Historical Data

The historical data trend for Arctic Bioscience AS's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Price-to-Owner-Earnings Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Arctic Bioscience AS's Price-to-Owner-Earnings

For the Biotechnology subindustry, Arctic Bioscience AS's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arctic Bioscience AS's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Arctic Bioscience AS's Price-to-Owner-Earnings falls into.


;
;

Arctic Bioscience AS Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Arctic Bioscience AS's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3.50/-3.22
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arctic Bioscience AS  (OSL:ABS) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Arctic Bioscience AS Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Arctic Bioscience AS Business Description

Traded in Other Exchanges
Address
Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines